Safety of tumor necrosis factor-alpha inhibitors for treatment of ankylosing spondylitis: A meta-analysis

BACKGROUND: Ankylosing spondylitis (AS) is a chronic immune-mediated disease affecting the sacroiliac joints and the spine, manifesting with new bone formation and osteopenia. Five tumor necrosis factor-alpha (TNF-α) inhibitors (infliximab, etanercept, adalimumab, certolizumab, and golimumab) are av...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zeren, Liu, Xiaoping, Xu, Xiaosheng, Jiang, Jie, Zhou, Jian, Wang, Jia, Chen, Dewang, Luo, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484196/
https://www.ncbi.nlm.nih.gov/pubmed/28640088
http://dx.doi.org/10.1097/MD.0000000000007145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484196/
https://www.ncbi.nlm.nih.gov/pubmed/28640088
http://dx.doi.org/10.1097/MD.0000000000007145

Ejemplares similares